Jiajia Zhang
Jiajia Zhang
Verified email at jhmi.edu
Cited by
Cited by
Neoadjuvant PD-1 blockade in resectable lung cancer
PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ...
New England Journal of Medicine 378 (21), 1976-1986, 2018
Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease
H Abu-Sbeih, D Faleck, B Ricciuti, R Mendelsohn, AR Naqash, J Cohen, ...
BioMed Central, 2019
Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease
H Abu-Sbeih, D Faleck, B Ricciuti, R Mendelsohn, AR Naqash, J Cohen, ...
BioMed Central, 2019
Resumption of immune checkpoint inhibitor therapy after immune-mediated colitis
H Abu-Sbeih, FS Ali, AR Naqash, DH Owen, S Patel, GA Otterson, ...
Journal of Clinical Oncology 37 (30), 2738, 2019
The mutation-associated neoantigen functional expansion of specific T cells (MANAFEST) assay: a sensitive platform for monitoring antitumor immunity
L Danilova, V Anagnostou, JX Caushi, JW Sidhom, H Guo, HY Chan, ...
Cancer immunology research 6 (8), 888-899, 2018
Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989–2012: a matched case–control study
J Zhang, C Haines, AJM Watson, AR Hart, MJ Platt, DM Pardoll, ...
Gut 68 (11), 1971-1978, 2019
A multidisciplinary toxicity team for cancer immunotherapy–related adverse events
J Naidoo, J Zhang, EJ Lipson, PM Forde, K Suresh, KF Moseley, S Mehta, ...
Journal of the National Comprehensive Cancer Network 17 (6), 712-720, 2019
Precision immuno-oncology: prospects of individualized immunotherapy for pancreatic cancer
J Zhang, CL Wolfgang, L Zheng
Cancers 10 (2), 39, 2018
Compartmental analysis of T-cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non–small cell lung cancer
J Zhang, Z Ji, JX Caushi, M El Asmar, V Anagnostou, TR Cottrell, ...
Clinical Cancer Research 26 (6), 1327-1337, 2020
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression≥ 50%
JF Gainor, H Rizvi, EJ Aguilar, F Skoulidis, BY Yeap, J Naidoo, ...
Annals of Oncology 31 (3), 404-411, 2020
Intratumoral adaptive immunosuppression and type 17 immunity in mismatch repair proficient colorectal tumors
NJ Llosa, B Luber, AJ Tam, KN Smith, N Siegel, AH Awan, H Fan, T Oke, ...
Clinical Cancer Research 25 (17), 5250-5259, 2019
Neoadjuvant nivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response.
JE Reuss, KN Smith, V Anagnostou, J Zhang, M Zahurak, J Caushi, ...
Journal of Clinical Oncology 37 (15_suppl), 8524-8524, 2019
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer
B Shankar, J Zhang, AR Naqash, PM Forde, JL Feliciano, KA Marrone, ...
JAMA oncology 6 (12), 1952-1956, 2020
Immune-related adverse events requiring hospitalization: spectrum of toxicity, treatment, and outcomes
A Balaji, J Zhang, B Wills, KA Marrone, H Elmariah, M Yarchoan, ...
Journal of oncology practice 15 (9), e825-e834, 2019
A multidisciplinary toxicity team for cancer immunotherapy-related adverse events.
J Naidoo, L Cappelli, EJ Lipson, PM Forde, WH Sharfman, J Zhang, ...
Journal of Clinical Oncology 36 (15_suppl), 6538-6538, 2018
Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and …
X Wang, Y Tian, Y Tang, ZH Hu, JJ Zhang, GS Fu, P Ma, H Ren, T Zhang, ...
Oncotarget 8 (24), 39727, 2017
A novel bioabsorbable pericardial membrane substitute to reduce postoperative pericardial adhesions in a rabbit model
Z Chen, J Zheng, J Zhang, S Li
Interactive cardiovascular and thoracic surgery 21 (5), 565-572, 2015
New development of biomarkers for gastrointestinal cancers: From neoplastic cells to tumor microenvironment
J Zhang, S Quadri, CL Wolfgang, L Zheng
Biomedicines 6 (3), 87, 2018
Immune-related adverse events requiring inpatient management: Spectrum of toxicity, treatment, and outcomes.
A Balaji, J Zhang, K Marrone, H Elmariah, M Yarchoan, M Holdhoff, ...
Journal of Clinical Oncology 36 (5_suppl), 138-138, 2018
Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and Clostridioides difficile
J Queen, J Zhang, CL Sears
Gut microbes 11 (4), 1092-1103, 2020
The system can't perform the operation now. Try again later.
Articles 1–20